Cao Sean Wuxiong sold 107,978 NovaBridge Biosciences shares at $0.74 per share on Sep 9, 2026. For investors, the reported ownership outcome is that Wuxiong retained 266,467 shares after the sale, while the transaction represented about 28.8% of his prior shares holding.

Key Highlights

  • Cao Sean Wuxiong is NovaBridge Biosciences’ Chief Business Development Officer.
  • The transaction carried code S.
  • NovaBridge Biosciences is listed on Nasdaq under NBP.

NovaBridge Biosciences (NASDAQ: NBP) officer Cao Sean Wuxiong sold 107,978 shares at $0.74 per share on Sep 9, 2026. The transaction represented about 28.8% of his prior shares holding, leaving him with 266,467 shares.

Transaction Details

Cao Sean Wuxiong, NovaBridge Biosciences’ Chief Business Development Officer, completed the sale at $0.74 per share. The transaction quantity was 107,978 shares of NovaBridge Biosciences. It carried transaction code S. NovaBridge Biosciences is listed on Nasdaq under NBP. Wuxiong was identified as an officer of NovaBridge Biosciences.

Post-Sale Holding Stands at 266,467 Shares

Wuxiong’s reported NovaBridge Biosciences holding stood at 266,467 shares after the transaction. The 28.8% figure is stated as an approximate share of his prior holding. The post-transaction balance is expressed in shares, while the percentage uses the earlier holding as its reference point.